IGT-303

N/A

Report date: 2026/05/05 20:00:16

Base Information

Drug NameIGT-303
Drug Alias NameIGT-303
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTEK receptor tyrosine kinase agonists
TargetsTEK receptor tyrosine kinase
Therapy Area/IndicationsRenal Insufficiency, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIngenia Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesIngenia Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsRenal Insufficiency, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A